François-Xavier Otte

Clinical impact of ⁶⁸ Ga‐prostate‐specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate‐specific antigen after treatment with curative intent: preliminary analysis of a multidisciplinary approach

Simone Albisinni, Carlos Artigas, Fouad Aoun et al. · British Journal of Urology · 2016 · 112 citations

Medicine, Nuclear Medicine, Oncology +17

Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V–STORM): a phase 2, open-label, randomised controlled trial

Piet Ost, Shankar Siva, Sigmund Brabrand et al. · The Lancet Oncology · 2025 · 68 citations

Medicine, Oncology, Radiation Oncology +16

Vertebral Hemangioma Mimicking Bone Metastasis in 68Ga—PSMA Ligand PET/CT

Carlos Artigas, François-Xavier Otte, Marc Lemort et al. · Clinical Nuclear Medicine · 2017 · 53 citations

Medicine, Oncology, Radiology +17

PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial

Piet Ost, Shankar Siva, Sigmund Brabrand et al. · European Urology Oncology · 2023 · 28 citations · Full text

Medicine, Oncology, Genitourinary Oncology +16

Oligometastatic Disease Detection with 68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical Impact

Carlos Artigas, Romain Diamand, Qaid Ahmed Shagera et al. · Cancers · 2021 · 20 citations · Full text

Medicine, Oncology, Urology +17